Decitabine, Cytarabine, GCSF for Refractory AML/MDS
Clinical trial NCT00740181 · TERMINATED
Trial details
- NCT number
- NCT00740181
- Sponsor
- Brown University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2010-02-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.